Generative AI: Your Future of Intelligence - Daily Briefing

Generative AI is rapidly moving from experimental phases to becoming an indispensable tool in critical business functions, significantly impacting mergers and acquisitions (M&A) and enterprise observability. An Accenture report released on March 17, 2026, indicates a substantial increase in companies leveraging generative AI for M&A activities, particularly in the pre-deal stages. The share of organizations investing in generative AI for pre-deal M&A rose to 46% in 2026, a notable jump from 31% in 2024. This growth reflects a keen interest in using the technology to streamline intensive tasks such as market research and due diligence, thereby shortening deal cycles by an estimated 10% to 30% and trimming costs by approximately 20%.^[1]

The increased adoption is driven by the technology's ability to provide faster information synthesis, pattern recognition, and scenario analysis, complementing human judgment in complex financial landscapes. While post-deal adoption of GenAI has also increased, moving from 18% to 27% over the same period, it lags behind pre-deal integration due to the more unstructured nature of post-deal value realization, which requires coordinated execution across diverse systems. Key players in this evolving landscape include Accenture, which conducted the survey of 650 senior dealmakers across 12 industries and 24 countries, and McKinsey, whose recent report underscored the transformative impact of generative AI in M&A dealmaking.^[1]

Beyond M&A, generative AI is also fundamentally changing enterprise observability, according to Elastic's "Landscape of Observability in 2026 Report" released on March 17, 2026. The report reveals that 85% of organizations currently utilize some form of generative AI for observability, a figure projected to climb to 98% within the next two years, making it a baseline expectation for platforms. This rapid integration is crucial because observability generates data at a scale that is impossible for humans to process manually. Generative AI automates pattern recognition and enables teams to query telemetry data using natural language, thus streamlining the correlation of logs, metrics, and traces during incidents. While current efficiency gains are often incremental, 68% of teams report improvements, and a substantial 56% anticipate "substantial gains" within five years as workflows adapt to these new capabilities.^[2]

The report further highlights the emerging role of "agentic AI" within observability, with 23% of organizations already using it and another 38% planning to adopt it. These agentic systems are designed to investigate issues, correlate data, and even execute autonomous remediation. This shift signifies a move towards more autonomous AI systems capable of performing complex tasks with minimal human intervention, although successful implementation strongly correlates with an organization's AI maturity.^[2]

In a significant stride for the healthcare and life sciences (HLS) sector, Persistent Systems announced on March 17, 2026, a collaboration with NVIDIA to accelerate the development and deployment of AI-powered solutions for computational drug discovery. This partnership aims to enhance research outcomes by leveraging Generative AI and advanced analytics to reimagine early-stage drug discovery. The core of this initiative is Persistent's new Generative Molecules and Virtual Screening (GenMoIVS) solution, which is powered by NVIDIA's BioNeMo platform and the NVIDIA NeMo Agent Toolkit.^[1]

The GenMoIVS solution is designed to deliver AI-driven molecular simulations, modeling the physical and chemical properties of molecules using large domain-specific models. It also creates intelligent agents to streamline real-time drug discovery workflows. This application of AI allows for high-fidelity molecular simulation and virtual screening at scale, enabling pharmaceutical companies and researchers to model and reason about real-world biological and chemical behavior before costly and time-consuming wet laboratory environments are engaged.^[1]

The collaboration addresses the immense pressure HLS organizations face to drive innovation within highly complex, regulated, and data-intensive environments. By combining Persistent's deep domain and engineering expertise with NVIDIA's full-stack AI platform, Life Sciences enterprises can transition from AI experimentation to real-world production deployments. Persistent will utilize NVIDIA AI Enterprise for specialized R&D use cases, including preclinical research. The impact of this collaboration is expected to accelerate the discovery of new treatments for various diseases, potentially saving billions in drug development costs by reducing trial and error, a trend also noted by MIT researchers in the broader context of AI in drug design.^[1][2]

NVIDIA made a pivotal announcement on March 17, 2026, introducing NVIDIA Dynamo 1.0, an open-source software designed as a distributed "operating system" for generative and agentic inference at scale. This breakthrough software, in conjunction with the NVIDIA Blackwell platform, aims to empower cloud providers, AI innovators, and global enterprises to achieve high-performance AI inference with unparalleled scale, efficiency, and speed.^[1]

As agentic AI systems transition into production across various industries, the challenge of scaling inference within data centers has become increasingly complex, demanding sophisticated resource orchestration for requests of varying sizes and modalities. Dynamo 1.0 addresses this by seamlessly orchestrating GPU and memory resources across clusters, functioning much like a computer's operating system coordinates hardware and applications for complex AI workloads. NVIDIA claims that recent industry benchmarks demonstrate Dynamo's ability to boost the inference performance of NVIDIA Blackwell GPUs by up to 7x, significantly reducing token cost and increasing revenue opportunities for millions of GPUs through free, open-source software.^[1]

NVIDIA founder and CEO Jensen Huang emphasized the importance of inference as "the engine of intelligence" for every AI query, agent, and application. He stated that with Dynamo, NVIDIA has created the first-ever "operating system" for AI factories, highlighting its rapid adoption across the ecosystem as proof that the "next wave of agentic AI is here." Dynamo 1.0 optimizes inference by splitting work across GPUs with smarter "traffic control" and managing data movement between GPUs and lower-cost storage, thereby reducing wasted effort and easing memory constraints. For agentic AI and long prompts, it intelligently routes requests to GPUs holding relevant "short-term memory" from previous steps, offloading it when no longer needed.^[1]

Orange Business convened its annual Summit on March 17-18, 2026, where it unveiled a suite of next-generation innovations focused on trusted AI, cloud, and secure connectivity. A significant announcement was the extension of its Live Intelligence platform with new plug-and-play generative AI capabilities to support customers with "trusted AI agents." Through Live Intelligence Studio, enterprises can now develop, deploy, and manage intelligent AI agents securely within a trusted infrastructure, aimed at automating tasks and analyzing data with a human-centric approach.^[1]

This initiative marks Orange Business's commitment to ushering customers into the "agentic era," where AI agents operate with a degree of autonomy and trustworthiness, integrating seamlessly into enterprise communications. Key features of these reimagined enterprise communications include branded calling, deepfake detection, AI-augmented customer care, and agentic telephony, all designed to enhance operational efficiency, strengthen security against sophisticated threats, and foster deeper, more trusted engagement between customers and employees.^[1]

The broader context of the Orange Business Summit emphasizes building resilience through trusted and transformative innovation, with smarter, faster, and safer solutions powered by AI and secure cloud environments. The company aims to empower organizations to scale and innovate securely in an increasingly unpredictable world. As an operator, integrator, and platform provider, Orange Business positions itself as a crucial bridge for businesses leveraging AI, showcasing cutting-edge demonstrations across trusted connectivity, cloud, cybersecurity, and AI, with a focus on responsible innovation and enhanced customer experience.^[1]

NVIDIA showcased significant advancements in AI during its annual GTC developer conference, which commenced on March 17, 2026. Among the highlights was the introduction of DLSS 5, a new AI-powered graphics rendering technology that promises to dramatically improve image realism while simultaneously reducing the computational load on hardware. According to NVIDIA founder and CEO Jensen Huang, DLSS 5 represents a "GPT moment for graphics," merging traditional 3D rendering with generative AI models that can predict and intelligently fill in missing visual details, leading to richer, more lifelike images at high performance.^[1]

This technological leap is poised to transform visual fidelity in gaming and other graphics-intensive applications. By integrating generative AI, DLSS 5 allows GPUs to render more complex scenes with greater efficiency, maintaining creative control for artists while pushing the boundaries of realism. This reflects a broader industry trend where AI is no longer merely augmenting graphics or computing but is becoming deeply embedded in the creation, simulation, and real-time experience of digital worlds.^[1]

On the hardware front, NVIDIA also announced plans for its next-generation AI computing system, Vera Rubin, slated for launch later in 2026. This system is projected to comprise approximately 1.3 million components and deliver up to ten times better performance per watt compared to its predecessor, the Grace Blackwell platform. Such improvements are critical given the escalating energy demands of large-scale AI models in data centers. Additionally, NVIDIA introduced a new software stack called NemoClaw, designed to support the development and deployment of AI agents on the OpenClaw platform, further underscoring the company's commitment to powering the next generation of autonomous AI systems.^[1]

A new study commissioned by the Directorate-General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission was released on March 17, 2026, analyzing the EU digital health market and the economic impact of digital health technologies, including AI-enabled solutions. This "Observatory for digital health technologies in Europe" study emphasizes the increasing integration of AI, particularly Generative AI, across the EU healthcare landscape, moving beyond mere experimentation into practical application.^[1]

The study's findings reveal a strong appetite for digital innovation within the sector, with 94% of healthcare providers either currently using AI solutions or planning to adopt them. AI is identified as a significant investment priority among EU digital health vendors, with 20% specifically investing in Generative AI and 23% in AI/ML more broadly. AI-powered diagnostic tools are highlighted as the most mature emerging technology, with adoption expected to reach almost 80% by 2029. Common applications include clinical decision support, early diagnosis, patient engagement, and remote monitoring.^[1]

Despite the promising growth - the EU digital health market is projected to expand from EUR 11 billion in 2023 to EUR 61.2 billion by 2035 - the report also points out structural challenges. EU startups and scale-ups focused on AI, virtual human twins, and digital therapeutics continue to face significant barriers to growth and cross-border expansion, primarily due to limited access to funding and finance. Nevertheless, the study underscores a sector-wide understanding that AI integration, particularly Generative AI, is becoming a strategic imperative for innovation and competitiveness in European healthcare.

^[1]

The financial services sector is grappling with the rapid evolution of generative artificial intelligence (GenAI) and its profound implications for model development, interpretability, and governance. A paper published in the Journal of Risk Model Validation on March 17, 2026, titled "Generative artificial intelligence in model risk management: emerging opportunities, supervisory challenges and validation frameworks," delves into this critical intersection. The research highlights how large language models and multimodal architectures are increasingly embedded in risk management, compliance, and operations, presenting both transformative opportunities and unprecedented supervisory challenges for financial institutions.^[1]

The paper extends existing regulatory principles, such as those in US Federal Reserve Supervisory Letter SR 11-7, to Generative AI through behavioral and semantic validation methods. It introduces quantitative proxies - including prompt-variance, stability, and human-alignment - to provide evidence of the reliability of GenAI's reasoning. A sanctions-screening case study within the paper demonstrates that GenAI can enhance precision and auditability under existing governance frameworks.^[1]

The authors conclude that effective oversight of GenAI requires an interpretive model-risk culture grounded in transparency, accountability, and human judgment. This emphasizes that while GenAI offers significant advantages in areas like fraud detection, business simulation, and enhanced machine learning by providing synthetic datasets without privacy concerns, its deployment must be accompanied by robust validation and governance frameworks. The financial industry's proactive engagement with these challenges is crucial for harnessing the full potential of GenAI while mitigating inherent risks.^[1][2]